2024-12-13 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Review

This report analyzes UnitedHealth Group Inc (UNH), a diversified healthcare company offering a range of health benefits programs and services.

**1. Performance Comparison with S&P 500 (VOO):**

UNH's cumulative return (147.25%) significantly outperforms the S&P 500's cumulative return (122.07%).  The difference is 25.2%, placing it at the 21st percentile of its historical range of outperformance relative to the S&P 500 (based on a range of -4.2% to 135.8%).  This indicates a consistent outperformance, though the recent underperformance needs further investigation.

**Alpha and Beta Analysis:**

The provided data shows consistently positive alpha (0.1) across all periods, indicating UNH has outperformed the market.  Beta is consistently high (around 0.1 to 1), suggesting high market sensitivity. Market cap consistently increased, reflecting company growth. However, the last period (2022-2024) shows a negative CAGR, highlighting recent market volatility's impact.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 58.0% | 1.8% | 30.0% | 0.1 | 181.0 |
| 2016-2018  | 66.0% | 10.5% | 47.0% | 0.1 | 208.0 |
| 2017-2019  | 52.0% | 10.5% | 21.0% | 0.1 | 249.0 |
| 2018-2020  | 32.0% | 10.5% | 5.0% | 0.1 | 302.0 |
| 2019-2021  | 96.0% | 9.4% | 26.0% | 0.1 | 439.0 |
| 2020-2022  | 102.0% | 5.5% | 93.0% | 0.1 | 469.0 |
| 2021-2023  | 60.0% | 5.5% | 37.0% | 0.1 | 473.0 |
| 2022-2024  | -11.0% | 12.1% | -51.0% | 0.1 | 487.0 |


**2. Recent Price Movement:**

* **Closing Price:** 533.53
* **5-Day Moving Average:** 556.72
* **20-Day Moving Average:** 587.59
* **60-Day Moving Average:** 581.31

The stock price is currently below all three moving averages, indicating a potential downtrend.  The last market price (528.9) is slightly lower than the closing price.  This signals the possibility of a recent price drop.

**3. Technical Indicators:**

* **RSI (28.38):**  Suggests the stock is currently in oversold territory.
* **PPO (-1.25):** Indicates bearish momentum.
* **Relative Strength Change (20-day):** -24.7%, showing a recent decline in relative strength.
* **Expected Return (321.8%):**  This represents a significant projected long-term (2+ years) outperformance against the S&P 500 if the stock returns to a previously established trend.

**4. Recent Earnings Analysis:**

The provided earnings data shows some volatility.  While revenue generally shows an upward trend, EPS is inconsistent, with a significant negative EPS in Q2 2024.  A direct comparison requires understanding the market expectations for each quarter, which is not provided.

| Date       | EPS     | Revenue      |
|------------|---------|---------------|
| 2024-11-04 | 6.56    | 100.82 B$     |
| 2024-08-09 | 4.58    | 98.86 B$     |
| 2024-05-09 | -1.53   | 99.80 B$     |
| 2023-11-06 | 6.31    | 92.36 B$     |
| 2024-11-04 | 6.31    | 92.36 B$     |


**5. Financial Information:**

Revenue shows consistent growth, although profit margins have fluctuated.  Equity has generally increased, but ROE has been inconsistent, including a negative value in Q1 2024. This suggests potential challenges in profitability despite revenue growth.


**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-09-30 | $99.18B   | 21.56%        |
| 2024-06-30 | $97.86B   | 21.52%        |
| 2024-03-31 | $98.78B   | 22.26%        |
| 2023-12-31 | $93.25B   | 22.33%        |
| 2023-09-30 | $91.36B   | 24.51%        |

**Capital and Profitability:**

| Quarter | Equity     | ROE     |
|---------|------------|---------|
| 2024-09-30 | $94.53B   | 6.41%   |
| 2024-06-30 | $89.36B   | 4.72%   |
| 2024-03-31 | $86.69B   | -1.63%  |
| 2023-12-31 | $88.76B   | 6.15%   |
| 2023-09-30 | $84.49B   | 6.91%   |


**6. News and Recent Issues:**

This section requires information on recent earnings news (within the last 2 days), market outlook, and analyst opinions, which were not provided.

**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, showing positive alpha. However, recent price action suggests a potential downtrend, supported by indicators like RSI and PPO. While revenue shows growth, inconsistent EPS and ROE raise concerns.  A deeper dive into the reasons behind the Q2 2024 negative EPS and the recent price drop is crucial.  The lack of recent news and analyst opinions limits a comprehensive assessment.  The high expected return hinges on a return to previous growth trajectories.

**8. Recommendations:**

Further investigation is needed to understand the reasons behind the recent decline in UNH's performance.  Analyzing the market expectations for each quarter, recent news impacting the stock, and analyst sentiment would provide a more complete picture.  The oversold RSI suggests a potential bounce, but the bearish momentum and lower-than-average price suggest caution.  A long-term investor might consider accumulating shares at these levels, but only after conducting thorough due diligence and considering the risks associated with the recent volatility.
